390
Views
17
CrossRef citations to date
0
Altmetric
Original

An antibody to IP-10 is a potent antagonist of cell migration in vitro and in vivo and does not affect disease in several animal models of inflammation

, , , , , , , , , , , , , , , , , , , , , , , , , , , , & show all
Pages 171-182 | Received 10 Oct 2008, Accepted 17 Nov 2008, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Xinaida Taligare Lima, Rômulo Tadeu Dias Oliveira, Fernanda Gambogi Braga, Renata Ferreira Magalhães, Ronei Luciano Mamoni & Maria Heloisa Souza Lima Blotta. (2015) Circulating levels of chemokines in psoriasis. Autoimmunity 48:1, pages 57-60.
Read now

Articles from other publishers (16)

Dominic SkinnerBrett S. MarroThomas E. Lane. (2019) Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease. Viral Immunology 32:1, pages 25-37.
Crossref
Carly E. Gregor, Jade Foeng, Iain Comerford & Shaun R. McColl. 2017. 119 181 .
Rodney M. Ritzel, Joshua Crapser, Anita R. Patel, Rajkumer Verma, Jeremy M. Grenier, Anjali Chauhan, Evan R. Jellison & Louise D. McCullough. (2016) Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury. The Journal of Immunology 196:8, pages 3318-3330.
Crossref
Raffaele AltaraMarco Manca, Rita D. Brandão, Asad Zeidan, George W. BoozFouad A. Zouein. (2016) Emerging importance of chemokine receptor CXCR3 and its ligands in cardiovascular diseases. Clinical Science 130:7, pages 463-478.
Crossref
Nichole M. Miller, Jun Wang, Yanping Tan & Bonnie N. Dittel. (2015) Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis. Frontiers in Neuroscience 9.
Crossref
Emily Mills Ko, Joyce H Ma, Fuzheng Guo, Laird Miers, Eunyoung Lee, Peter Bannerman, Travis Burns, David Ko, Jiho Sohn, Athena M Soulika & David Pleasure. (2014) Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model. Journal of Neuroinflammation 11:1.
Crossref
Stephen J. Lalor & Benjamin M. Segal. (2013) Th1-mediated experimental autoimmune encephalomyelitis is CXCR3 independent. European Journal of Immunology 43:11, pages 2866-2874.
Crossref
Eun Young Lee, Zang Hee Lee & Yeong Wook Song. (2013) The interaction between CXCL10 and cytokines in chronic inflammatory arthritis. Autoimmunity Reviews 12:5, pages 554-557.
Crossref
Ann E. Østvik, Atle vB Granlund, Marit Bugge, Nadra J. Nilsen, Sverre H. Torp, Helge L. Waldum, Jan K. Damås, Terje Espevik & Arne K. Sandvik. (2013) Enhanced Expression of CXCL10 in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 19:2, pages 265-274.
Crossref
Emanuele Tirotta, Leslie A. Kirby, Maya N. Hatch & Thomas E. Lane. (2012) IFN-γ-induced apoptosis of human embryonic stem cell derived oligodendrocyte progenitor cells is restricted by CXCR2 signaling. Stem Cell Research 9:3, pages 208-217.
Crossref
D. Hammaker, D. L. Boyle & G. S. Firestein. (2011) Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis. Rheumatology 51:4, pages 610-618.
Crossref
Carola T. Murphy, Kenneth Nally, Fergus Shanahan & Silvia Melgar. (2012) Shining a Light on Intestinal Traffic. Clinical and Developmental Immunology 2012, pages 1-14.
Crossref
Pim J. Koelink, Saskia A. Overbeek, Saskia Braber, Petra de Kruijf, Gert Folkerts, Martine J. Smit & Aletta D. Kraneveld. (2012) Targeting chemokine receptors in chronic inflammatory diseases: An extensive review. Pharmacology & Therapeutics 133:1, pages 1-18.
Crossref
Julie Ho, David N. Rush, Martin Karpinski, Leroy Storsley, Ian W. Gibson, Jennifer Bestland, Ang Gao, William Stefura, Kent T. HayGlass & Peter W. Nickerson. (2011) Validation of Urinary CXCL10 As a Marker of Borderline, Subclinical, and Clinical Tubulitis. Transplantation 92:8, pages 878-882.
Crossref
M Zhang, K Howard, A Winters, S Steavenson, S Anderson, S Smelt, G Doellgast, C Sheelo, J Stevens, H Kim, A Hamburger, A Sein, D J Caughey, F Lee, H Hsu, G Siu & F R Byrne. (2011) Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis , but not trans , format relative to the activating stimulus . Clinical and Experimental Immunology 163:1, pages 77-87.
Crossref
Charlotte Israelsson, Henrik Bengtsson, Anna Lobell, Lars N. G. Nilsson, Annika Kylberg, Magnus Isaksson, Hanna Wootz, Lars Lannfelt, Klas Kullander, Lars Hillered & Ted Ebendal. (2010) Appearance of Cxcl10 ‐expressing cell clusters is common for traumatic brain injury and neurodegenerative disorders . European Journal of Neuroscience 31:5, pages 852-863.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.